Scorpius BioManufacturing

Joe Payne, Scorpius BioManufacturing, explains why CDMOs are essential to biopharma drug development.

A Different CDMO Experience: Q&A With Scorpius’ President & COO Joe Payne

Learn about Scorpius’ president and COO, Joe Payne, as a thought leader who is also approachable, energetic, and in-tune with client needs.

Learn about Scorpius’ competitive advantages in biomanufacturing of small-volume, early-stage large molecules.

Learn what it takes to produce an end product that can be shared with both prospective clients and prospective employees.

Videos

Joe Payne, Scorpius BioManufacturing, comments on the unique needs of today's biopharmaceutical companies looking to develop and manufacture small-volume, early-stage large molecules.

Articles

Ensure the success of clinical biomanufacturing programs by focusing on key tech transfer practices from the sponsor, commercial, scientific, and program management stakeholders.

Best Practices for Tech Transfer to Avoid Manufacturing Pitfalls

The sponsor, commercial, scientific, and program management teams each play a crucial role in the tech transfer process. Hear real-world tips from each of these stakeholders in this webinar.

https://www.biopharminternational.com/bp_w/avoid-manufacturing-pitfalls

Your clinical biomanufacturing program can be derailed if you don't pay attention to tech transfer details. Sponsors and CDMOs are eager to get contracts signed, but often overlook the crucial steps in the tech transfer process that will set the program up for success.
The sponsor, commercial, scientific, and program management teams each play a crucial role in the process. Hear from each of these stakeholders and gain insight based on real-world examples from recent tech transfers for early-stage clinical programs.

Ways a successful tech transfer can save you time–and therefore money–in the long-run

What you need from your current CDMO before you switch partners

Commons mistakes made during the tech transfer process (and how to avoid them)

The nuances of tech transfer that matter most

How to prepare for tech transfer before you select a CDMO

Key mistakes to avoid during the tech transfer process


VP, Process Sciences
Scorpius BioManufacturing

Brian O'Mara, Scorpius' VP of Process Sciences, has 20-plus years of experience in downstream process development of early- and late-stage protein therapeutics from mammalian and microbial expression systems. He also has extensive experience the development of protein conjugates, including ADCs, bi-specifics, and PEGylated molecules. He has experience in scale-up and technology transfer, CDMO management, process characterization, preparation and oversight of PPQ campaigns, and associated CMC regulatory filings.




Director, Business Development
Scorpius BioManufacturing

Kris Morton has more than 10 years of experience in process engineering and commercial operations. His background in process automation and optimization, tech transfer, equipment and process validation, and financial modeling make him an asset to sponsors with clinical manufacturing programs. Kris holds a BS in Chemical Engineering and Biochemistry & Molecular Biology from Rose-Hulman Institute of Technology, and both an MS (Finance) and an MBA from Indiana University’s Kelley School of Business




Sr. Marketing Manager
Scorpius BioManufacturing

Abby Sorensen joined Scorpius BioManufacturing after spending nine years in media. Her experience includes business development, content creation, trade show planning and execution, and project management. She has consulted on biopharma marketing strategies for Fortune 500 companies as well as startups. In her role at Scorpius, she also assists clients with their marketing strategy to help elevate their awareness to the investor and partnering community.

Webcasts

Webinar Date/Time: Tue, Mar 5, 2024 2:00 PM EST




Avoid Clinical Manufacturing Pitfalls With These 4 Tech Transfer Best Practices

Demonstrate that Scorpius has the expertise to bring large molecule drugs to the clinic

Make the industry aware we have immediately available capacity

Explain how Scorpius values the client-CDMO partnership